lenalid 5mg (Lenalidomide)
Lenalidomide 5 mg is an immunomodulatory medication used primarily in the treatment of certain blood cancers and hematological disorders.
Shop
Showing 57–84 of 104 results
-
-
Lenvat 10mg (Lenvatinib)
Lenvat (Lenvatinib): Overview, Uses, and Safety Information Lenvat (lenvatinib) is an oral anticancer medication classified as a tyrosine kinase inhibitor (TKI). It works by blocking specific proteins involved in tumor growth and the formation of new blood vessels that supply cancer cells. By targeting these pathways, lenvatinib can help slow or stop the progression of…
-
Lenvat 4mg (Lenvatinib)
Lenvat (lenvatinib) is an oral anticancer medication classified as a tyrosine kinase inhibitor (TKI). It works by blocking specific proteins involved in tumor growth and the formation of new blood vessels that supply cancer cells. By targeting these pathways, lenvatinib can help slow or stop the progression of certain cancers.
-
Lenvima (Lenvatinib) 10 mg
Lenvima targets multiple receptor tyrosine kinases involved in tumor angiogenesis and cancer progression. By inhibiting these pathways, it may help slow tumor growth and limit the blood supply that tumors need to grow and spread.
-
Lenvima (Lenvatinib) 4mg
Lenvima targets multiple receptor tyrosine kinases involved in tumor angiogenesis and cancer progression. By inhibiting these pathways, it may help slow tumor growth and limit the blood supply that tumors need to grow and spread.
-
Loncastuximab Tesirine-Lpyl/Zynlonta
Loncastuximab tesirine is a targeted anticancer therapy approved for the treatment of adults with relapsed or refractory large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma (DLBCL), after two or more lines of systemic therapy.
-
LORBRENA (lorlatinib)
LORBRENA is an advanced targeted therapy designed for adults diagnosed with ALK-positive metastatic non-small cell lung cancer (NSCLC).
-
Lunsumio (Mosunetuzumab)
Lunsumio is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma who have received two or more prior lines of systemic therapy.
-
Lynparza (Olaparib)
Lynparza (olaparib) is a targeted anticancer medication that belongs to a class of drugs known as poly (ADP-ribose) polymerase (PARP) inhibitors. It was the first PARP inhibitor approved for clinical use and has become an important treatment option for several cancers associated with defects in DNA repair mechanisms, particularly those involving BRCA gene mutations.
-
Maball 500mg Injection (Rituximab)
Maball 500mg Injection is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.
-
MabThera (Rituximab)
MabThera (rituximab) is a chimeric monoclonal antibody that selectively targets the CD20 antigen present on B lymphocytes.
-
Mekinist (Trametinib)
Mekinist (Trametinib): Uses, Benefits, and Important Safety Information
What Is Mekinist?
Mekinist (trametinib) is a prescription medication used in the treatment of certain types of cancer that have specific genetic mutations. It belongs to a class of targeted therapies known as MEK inhibitors, which work by blocking signals that help cancer cells grow and divide.
Healthcare providers may prescribe Mekinist alone or in combination with other targeted therapies, depending on the patient’s diagnosis and molecular testing results.
-
Mektovi (Binimetinib)
Binimetinib
It is a targeted cancer therapy used mainly in combination treatments for certain types of advanced melanoma.
-
MONJUVI (tafasitamab)
MONJUVI (tafasitamab) is a CD19-directed cytolytic monoclonal antibody used in the treatment of certain B-cell malignancies. It is designed to target the CD19 protein expressed on the surface of B cells, helping the immune system identify and eliminate malignant cells.
-
Navelbine (vinorelbine)
Navelbine is indicated for the treatment of non-small cell lung cancer and metastatic breast cancer.It works by interfering with the ability of cancer cells to divide, which slows or stops tumor growth.
-
Nindanib 100 mg Capsule (Nintedanib)
Nindanib 100 Soft Gelatin Capsule is used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer. It works by targeting certain pathways involved in the growth and progression of these diseases and helps to stop or slow the spread of cancer cells.
-
Nindanib 150mg capsule (Nintedanib)
Nindanib 150 Soft Gelatin Capsule is used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer. It works by targeting certain pathways involved in the growth and progression of these diseases and helps to stop or slow the spread of cancer cells.
-
Nubeqa (Darolutamide)
Nubeqa (darolutamide) is a prescription medication used to treat certain types of prostate cancer in adult men. It belongs to a class of medicines known as androgen receptor inhibitors, which work by blocking the effects of testosterone and other male hormones that can stimulate the growth of prostate cancer cells.
-
Pivikto 150mg Tablet (Alpelisib)
Pivikto is a prescription anticancer medicine containing Alpelisib, a targeted therapy that belongs to a class of drugs known as PI3K inhibitors. It is used in combination with fulvestrant for the treatment of certain types of advanced or metastatic breast cancer in patients whose tumors have a PIK3CA gene mutation.
-
POLIVY (Polatuzumab Vedotin)
Polivy is indicated for the treatment of adult patients with:
• Previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL) in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
• Relapsed or refractory DLBCL after at least two prior therapies, in combination with bendamustine and rituximab. -
Pomalid 2mg (Pomalidomide)
Pomalid (generic name: pomalidomide) is an immunomodulatory medication primarily used in the treatment of multiple myeloma, a type of blood cancer that affects plasma cells in the bone marrow. It belongs to a class of drugs known as immunomodulatory agents and is structurally related to thalidomide and lenalidomide.
-
Pomalid 4mg (Pomalidomide)
Pomalid (generic name: pomalidomide) is an immunomodulatory medication primarily used in the treatment of multiple myeloma, a type of blood cancer that affects plasma cells in the bone marrow. It belongs to a class of drugs known as immunomodulatory agents and is structurally related to thalidomide and lenalidomide.
-
Ponatinib/Iclusig
Ponatinib is a third-generation tyrosine kinase inhibitor (TKI) used primarily for the treatment of certain forms of leukemia, particularly chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
-
Poteligeo (mogamulizumab)
Poteligeo (mogamulizumab-kpkc) is a humanized monoclonal antibody indicated for the treatment of certain adults with relapsed or refractory cutaneous T-cell lymphoma (CTCL), including mycosis fungoides (MF) and Sézary syndrome (SS), after at least one prior systemic therapy.
-
Regonat Tablet 40mg (Regorafenib)
Regonat is a prescription anticancer medication that contains regorafenib as its active ingredient. It belongs to a class of medicines known as multikinase inhibitors, which work by blocking specific enzymes involved in tumor growth and the formation of new blood vessels that supply cancer cells.
-
Rybrevant® (amivantamab)
Rybrevant (amivantamab) is a prescription medication designed to treat certain adults with non-small cell lung cancer (NSCLC) whose tumors have specific genetic alterations in the EGFR gene.It is a bispecific antibody that targets both EGFR (epidermal growth factor receptor) and MET (mesenchymal-epithelial transition factor) pathways, which can contribute to tumor growth and survival.
-
Sorafenat (Sorafenib)
Sorafenib works by blocking specific enzymes (kinases) that help cancer cells grow and form new blood vessels. Liver cancer (hepatocellular carcinoma) Kidney cancer (renal cell carcinoma) Thyroid cancer (advanced, radioactive iodine–resistant)
-
Stivarga (Regorafenib)
Stivarga (regorafenib) is an oral prescription medication used to treat certain types of advanced cancers. It belongs to a class of targeted therapies known as multikinase inhibitors, which work by blocking specific proteins involved in tumor growth and the formation of new blood vessels that feed cancer cells.